[{"Assets_0_Q1_USD":1866808000.0,"CommonStockSharesConverted_0_Q1_shares":50067000.0,"CommonStockSharesOutstanding_0_Q1_shares":50067000.0,"EarningsPerShareBasic_1_Q1_USD":-2.31,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":-108822000.0,"NetIncomeLossConverted_1_Q1_USD":-115126000.0,"RevenuesConverted_1_Q1_USD":15957000.0,"StockholdersEquity_0_Q1_USD":1570201000.0,"Ticker":"BLUE","CIK":"1293971","name":"BLUEBIRD BIO, INC.","OfficialName":"bluebird bio Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"301448421.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20180502"}]